Back to results
US 2002/0119969 A1Published application
Novel process
OwnerSoren Ebdrup, Flemming Elmelund Nielseninventors
Life of this patent
Estimating the term…
Abstract
The present invention relates to a novel processes for preparing pharmaceutically active fused 1,2,4-thiadiazine derivatives of general formula (I) as defined in the description and intermediates therefore.
Claims23
A process for the preparation of a compound of formula (I)
- 14
- wherein
- X is NR2R3, SR1, S(═O)R1, S(═O)2R1 or OR1;
- R1 is hydrogen;
- C3-6-cycloalkyl or (C3-6-cycloalkyl)C1-6-alkyl, wherein the C3-6-cycloalkyl group is optionally mono- or polysubstituted with C1-6-alkyl, halogen, hydroxy or C1-6-alkoxy;
- a 3-6 membered saturated ring system comprising one or more nitrogen-, oxygen- or sulfur atoms, optionally being mono- or polysubstituted with halogen, cyano, trifluoromethyl, C1-6-alkyl, C1-6-alkoxy, C1-6-alkoxy-C1-6-alkyl, aryl, arylalkyl, hydroxy, oxo, nitro, amino, C1-6-monoalkyl or dialkylamino;
- straight or branched C1-18-alkyl, C2-18-alkenyl or C2-18-alkynyl, wherein each of the groups is optionally mono- or polysubstituted with halogen, hydroxy, C1-6-alkoxy, C1-6-alkylthio, C3-6-cycloalkyl, nitro, amino, C1-6-monoalkyl- or dialkylamino, cyano, oxo, formyl, acyl, carboxy, C1-6-alkoxycarbonyl, carbamoyl, formylamino, C1-6-alkylcarbonylamino, aryl, aryloxy, arylalkoxy;
- or bicycloalkyl, aryl, heteroaryl, arylalkyl or heteroarylalkyl, wherein each of the groups is optionally mono- or polysubstituted with halogen, hydroxy, C1-6-alkyl, C1-6-alkoxy, aryloxy, arylalkoxy, nitro, amino, C1-6-monoalkyl- or dialkylamino, cyano, oxo, acyl or C1-6-alkoxycarbonyl;
- R2 is hydrogen;
- hydroxy;
- C1-6-alkoxy;
- or C1-6-alkyl, C3-6-cycloalkyl, C2-6-alkenyl or C2-6-alkynyl optionally mono- or polysubstituted with halogen;
- R3 is hydrogen;
- C3-6-cycloalkyl or (C3-6-cycloalkyl)C1-6-alkyl, wherein the C3-6-cycloalkyl group is optionally mono- or polysubstituted with C1-6-alkyl, halogen, hydroxy or C1-6-alkoxy;
- a 3-6 membered saturated ring system comprising one or more nitrogen-, oxygen- or sulfur atoms;
- or straight or branched C1-18-alkyl optionally mono- or polysubstituted with halogen, hydroxy, C1-6-alkoxy, C1-6-alkylthio, C3-6-cycloalkyl, aryl, aryloxy, arylalkoxy, nitro, amino, C1-6-monoalkyl- or dialkylamino, cyano, oxo, formyl, acyl, carboxy, C1-6-alkoxycarbonyl, or carbamoyl;
- or
- R3 is —OR4;
- —C(═Z)R4;
- —NR4R5;
- or bicycloalkyl, aryl, heteroaryl, arylalkyl or heteroarylalkyl, optionally mono- or polysubstituted with halogen, hydroxy, C1-6-alkyl, C1-6-alkoxy, aryloxy, arylalkoxy, nitro, amino, C1-6-monoalkyl- or dialkylamino, cyano, oxo, acyl or C1-6-alkoxycarbonyl;
- R4 is hydrogen;
- C3-6-cycloalkyl or (C3-6-cycloalkyl)C1-6-alkyl, wherein the C3-6-cycloalkyl group is optionally mono- or polysubstituted with C1-6-alkyl, halogen, hydroxy or C1-6-alkoxy;
- a 3-6 membered saturated ring system comprising one or more nitrogen-, oxygen- or sulfur atoms;
- or straight or branched C1-18-alkyl optionally mono- or polysubstituted with halogen, hydroxy, C1-6-alkoxy, C1-6-alkylthio, C3-6-cycloalkyl, aryl, aryloxy, arylalkoxy, nitro, amino, C1-6-monoalkyl- or dialkylamino, cyano, oxo, formyl, acyl, carboxy, C1-6-alkoxycarbonyl, or carbamoyl;
- Z is O or S;
- R5 is hydrogen;
- C1-6-alkyl;
- C2-6-alkenyl;
- C3-6-cycloalkyl optionally mono- or polysubstituted with C1-6-alkyl, halogen, hydroxy or C1-6-alkoxy;
- or
- when R3 is —NR4R5, R4 and R5 together with the nitrogen atom form a 3-12 membered mono- or bicyclic system, in which one or more of the carbon atoms may be exchanged with nitrogen, oxygen or sulfur, each of these ring systems optionally being mono- or polysubstituted with halogen, C1-6-alkyl, hydroxy, C1-6-alkoxy, C1-6-alkoxy-C1-6-alkyl, nitro, amino, cyano, trifluoromethyl, C1-6-monoalkyl- or dialkylamino, or oxo;
- or
- when X is —NR2R3, R2 and R3 together with the nitrogen atom form a 3-12 membered mono- or bicyclic system, in which one or more of the carbon atoms may be exchanged with nitrogen, oxygen or sulfur, each of these ring systems optionally being mono- or polysubstituted with halogen, C1-6-alkyl, hydroxy, C1-6-alkoxy, C1-6-alkoxy-C1-6-alkyl, nitro, amino, cyano, trifluoromethyl, C1-6-monoalkyl- or dialkylamino or oxo;
- A together with the carbon atoms forming bond e of formula I represents a 5 membered heterocyclic system comprising one or more nitrogen-, oxygen- or sulfur atoms, the heterocyclic system optionally being mono- or polysubstituted with halogen;
- C1-18-alkyl;
- C3-6-cycloalkyl;
- hydroxy;
- C1-6-alkoxy;
- C1-6-alkoxy-C1-6-alkyl;
- nitro;
- amino;
- cyano;
- cyanomethyl;
- perhalomethyl;
- C1-6-monoalkyl- or dialkylamino;
- sulfamoyl;
- C1-6-alkylthio;
- C1-6-alkylsulfonyl;
- C1-6-alkylsulfinyl;
- C1-6-alkylcarbonylamino;
- arylthio, arylsulfinyl, arylsulfonyl, aryl, arylalkyl, or aryloxy, wherein the aryl group is optionally mono- or polysubstituted with C1-6-alkyl, perhalomethyl, halogen, hydroxy or C1-6-alkoxy;
- C1-6-alkoxycarbonyl;
- C1-6-alkoxycarbonyl-C1-6-alkyl;
- carbamyl;
- carbamylmethyl;
- C1-6-monoalkyl- or dialkylaminocarbonyl;
- C1-6-monoalkyl- or dialkylaminothiocarbonyl;
- ureido;
- C1-6-monoalkyl- or dialkylaminocarbonylamino;
- thiocarbamyl;
- thioureido;
- C1-6-monoalkyl- or dialkylaminothiocarbonyl-amino;
- C1-6-monoalkyl- or dialkylaminosulfonyl;
- carboxy;
- carboxy-C1-6-alkyl;
- acyl;
- formyl;
- or a 5-6 membered nitrogen, oxygen or sulfur containing ring, optionally substituted with C1-6-alkyl or phenyl, wherein the phenyl group is optionally mono- or polysubstituted with C1-6-alkyl, perhalomethyl, halogen, hydroxy or C1-6-alkoxy;
- or
- a salt thereof with a pharmaceutically acceptable acid or base, or an optical isomer thereof, or a tautomeric form thereof, or metabolites or prodrugs thereof, comprising one of the following methods:
- a) reacting a compound of formula (II)
- 15
- wherein A is as defined above, L is a leaving group selected from alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, nitro or halogen and Q is halogen, with a compound of formula (III),
- 16
- wherein X is NR2R3, wherein R2 and R3 are defined above, or a suitable salt thereof, in the presence of a base in solvent 1, to form a compound of formula (IV)
- 17
- wherein A, L and X are as defined above, and cyclizing the compound of formula (IV) in solvent 2, optionally in the presence of a base, and optionally with a metal catalyst, to form a compound of formula (I), or
- b) reacting a compound of formula (II)
- 18
- wherein A is as defined above, L is a leaving group selected from alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl or halogen and Q is halogen, with a compound of formula (III)
- 19
- wherein X is SR1, S(═O)R1 or S(═O)2R1, wherein R1 is defined above, or a suitable salt thereof, in the presence of a base in solvent 1, to form a compound of formula (IV)
- 20
- wherein A, L and X are as defined above, and cyclizing the compound of formula (IV) in solvent 2, optionally in the presence of a base, and optionally with a metal catalyst, to form a compound of formula (I), or
- c) reacting a compound of formula (II)
- 21
- wherein A is as defined above, L is a leaving group selected from alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl or halogen and Q is halogen, with a compound of formula (III),
- 22
- wherein X is OR1, wherein R1 is defined above, or a suitable salt thereof, in the presence of a base in solvent 1, to form a compound of formula (IV)
- 23
- wherein A, L and X are as defined above, and cyclizing the compound of formula (IV) in solvent 2, optionally in the presence of a base, and optionally with a metal catalyst, to form a compound of formula (I), or
- d) transforming a compound of formula (IV) to a compound of formula (IV′)
- 24
- wherein A, L and X are as defined above, and X is transformed into X′, wherein X′ is selected from the groups defined for X, with the proviso that X′≠X, and cyclizing the compound of formula (IV′) in solvent 2, optionally in the presence of a base, and optionally with a metal catalyst, to form a compound of formula (I), or
- e) transforming a compound of formula (I), prepared as described above, by oxidation or substitution or both, to form another compound of formula (I).
93 more elements
Dependencies are inferred from the claim text.